G Weigert
Overview
Explore the profile of G Weigert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sacu S, Michels S, Prager F, Weigert G, Dunavoelgyi R, Geitzenauer W, et al.
Eye (Lond)
. 2009 Jan;
23(12):2223-7.
PMID: 19169239
Purpose: To compare 1-year functional and anatomic outcomes of intravitreal bevacizumab (IVB) and photodynamic therapy plus intravitreal triamcinolone (PDT+IVTA) combination in patients with neovascular age-related macular degeneration (AMD). Methods: In...
2.
Sacu S, Varga A, Michels S, Weigert G, Polak K, Vecsei-Marlovits P, et al.
Br J Ophthalmol
. 2008 Jul;
92(10):1347-51.
PMID: 18586901
Background: To compare early treatment effect of reduced fluence versus standard photodynamic therapy (rPDT, sPDT, respectively) in combination with intravitreal triamcinolone (IVTA) in neovascular age-related macular degeneration. Methods: Forty patients...
3.
Kircher K, Weigert G, Resch H, Garhofer G, Dorner G, Fuchsjager Mayrl G, et al.
Graefes Arch Clin Exp Ophthalmol
. 2008 Jun;
246(10):1423-7.
PMID: 18575879
Background: In this study, patients with optic neuritis were treated with high-dose prednisolone. Little information is available about the effects of this treatment on ocular blood flow. We set out...
4.
Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, et al.
Br J Ophthalmol
. 2008 Feb;
92(3):356-60.
PMID: 18303156
Aims: To compare functional and anatomical outcomes of intravitreal bevacizumab (Avastin) and verteporfin (photodynamic) therapy (PDT) combined with intravitreal triamcinolone (IVTA) in patients with neovascular age-related macular degeneration (AMD). Methods:...
5.
Hahn R, Sacu S, Michels S, Varga A, Weigert G, Geitzenauer W, et al.
Ophthalmologe
. 2007 Jun;
104(7):588-93.
PMID: 17564719
Aim: The aim of this study was to compare intravitreal bevacizumab (IVB) and verteporfin therapy in combination with 4 mg intravitreal triamcinolone (PDT-IVTA) in patients with neovascular age-related macular degeneration...
6.
Fuchsjager-Mayrl G, Wally B, Rainer G, Buehl W, Aggermann T, Kolodjaschna J, et al.
Br J Ophthalmol
. 2005 Sep;
89(10):1293-7.
PMID: 16170119
Background: There is evidence that perfusion abnormalities of the optic nerve head are involved in the pathogenesis of glaucoma. There is therefore considerable interest in the effects of topical antiglaucoma...
7.
Wimpissinger B, Resch H, Berisha F, Weigert G, Schmetterer L, Polak K
Br J Ophthalmol
. 2004 May;
88(6):776-81.
PMID: 15148211
Aim: To investigate a potential difference in ocular vascular reactivity during carbogen breathing in optic nerve head, choroid, and retina between healthy smokers and non-smokers. Methods: 25 (13 smokers and...
8.
Garcia M, Weigert G, Duk S, Alarcon M
Bull Environ Contam Toxicol
. 1999 Feb;
62(2):117-21.
PMID: 9933307
No abstract available.
9.
Garcia M, Duk S, Weigert G, Becerra J, Silva M, Alarcon M
Bull Environ Contam Toxicol
. 1993 Dec;
51(6):803-7.
PMID: 8257804
No abstract available.
10.
Garcia M, Alarcon M, Duk S, Weigert G
Bull Environ Contam Toxicol
. 1992 Dec;
49(6):866-70.
PMID: 1450567
No abstract available.